GO:0004832 | valine-tRNA ligase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0016032 | viral process | 1.90e-03 | 1.00e+00 | 2.811 | 4 | 30 | 428 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.09e-03 | 1.00e+00 | 4.853 | 2 | 8 | 52 |
GO:0045666 | positive regulation of neuron differentiation | 2.17e-03 | 1.00e+00 | 4.825 | 2 | 3 | 53 |
GO:0033688 | regulation of osteoblast proliferation | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0007411 | axon guidance | 3.37e-03 | 1.00e+00 | 3.249 | 3 | 8 | 237 |
GO:0004346 | glucose-6-phosphatase activity | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0015760 | glucose-6-phosphate transport | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0005654 | nucleoplasm | 4.01e-03 | 1.00e+00 | 2.100 | 5 | 68 | 876 |
GO:0001649 | osteoblast differentiation | 4.19e-03 | 1.00e+00 | 4.344 | 2 | 5 | 74 |
GO:0010467 | gene expression | 4.28e-03 | 1.00e+00 | 2.490 | 4 | 49 | 535 |
GO:0036089 | cleavage furrow formation | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0033234 | negative regulation of protein sumoylation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 5 |
GO:0043931 | ossification involved in bone maturation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0005672 | transcription factor TFIIA complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 3 | 6 |
GO:0051156 | glucose 6-phosphate metabolic process | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0043297 | apical junction assembly | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0035615 | clathrin adaptor activity | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0007049 | cell cycle | 9.85e-03 | 1.00e+00 | 3.707 | 2 | 8 | 115 |
GO:0090307 | spindle assembly involved in mitosis | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 4 | 8 |
GO:0043296 | apical junction complex | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0030122 | AP-2 adaptor complex | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 9 |
GO:0030100 | regulation of endocytosis | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 9 |
GO:0048268 | clathrin coat assembly | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 9 |
GO:0072583 | clathrin-mediated endocytosis | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 9 |
GO:0000398 | mRNA splicing, via spliceosome | 1.21e-02 | 1.00e+00 | 3.553 | 2 | 15 | 128 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0050919 | negative chemotaxis | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 4 | 11 |
GO:0017025 | TBP-class protein binding | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 12 |
GO:0050772 | positive regulation of axonogenesis | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.87e-02 | 1.00e+00 | 3.222 | 2 | 18 | 161 |
GO:0008380 | RNA splicing | 1.96e-02 | 1.00e+00 | 3.187 | 2 | 21 | 165 |
GO:0000188 | inactivation of MAPK activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 15 |
GO:0032467 | positive regulation of cytokinesis | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 2 | 16 |
GO:0005496 | steroid binding | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 1 | 17 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 19 |
GO:0071897 | DNA biosynthetic process | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 20 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.78e-02 | 1.00e+00 | 2.916 | 2 | 8 | 199 |
GO:0050690 | regulation of defense response to virus by virus | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 1 | 22 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 2 | 23 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 1 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 6 | 24 |
GO:0030054 | cell junction | 3.29e-02 | 1.00e+00 | 2.785 | 2 | 5 | 218 |
GO:0051496 | positive regulation of stress fiber assembly | 3.41e-02 | 1.00e+00 | 4.853 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.54e-02 | 1.00e+00 | 4.798 | 1 | 4 | 27 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.67e-02 | 1.00e+00 | 4.746 | 1 | 2 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 6 | 29 |
GO:0032154 | cleavage furrow | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 3 | 30 |
GO:0006094 | gluconeogenesis | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 1 | 31 |
GO:0035914 | skeletal muscle cell differentiation | 4.31e-02 | 1.00e+00 | 4.509 | 1 | 3 | 33 |
GO:0021762 | substantia nigra development | 4.44e-02 | 1.00e+00 | 4.466 | 1 | 1 | 34 |
GO:0007254 | JNK cascade | 4.44e-02 | 1.00e+00 | 4.466 | 1 | 1 | 34 |
GO:0008565 | protein transporter activity | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 2 | 35 |
GO:0050434 | positive regulation of viral transcription | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 5 | 35 |
GO:0007266 | Rho protein signal transduction | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 2 | 35 |
GO:0008645 | hexose transport | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 8 | 36 |
GO:0030334 | regulation of cell migration | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 2 | 36 |
GO:0030666 | endocytic vesicle membrane | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 1 | 36 |
GO:0046982 | protein heterodimerization activity | 4.70e-02 | 1.00e+00 | 2.503 | 2 | 11 | 265 |
GO:0006396 | RNA processing | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 6 | 40 |
GO:0032481 | positive regulation of type I interferon production | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 3 | 48 |
GO:0015758 | glucose transport | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 8 | 48 |
GO:0016020 | membrane | 6.65e-02 | 1.00e+00 | 1.316 | 4 | 56 | 1207 |
GO:0006289 | nucleotide-excision repair | 6.83e-02 | 1.00e+00 | 3.825 | 1 | 6 | 53 |
GO:0005694 | chromosome | 7.08e-02 | 1.00e+00 | 3.772 | 1 | 4 | 55 |
GO:0016311 | dephosphorylation | 7.08e-02 | 1.00e+00 | 3.772 | 1 | 3 | 55 |
GO:0007596 | blood coagulation | 7.28e-02 | 1.00e+00 | 2.148 | 2 | 13 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.36e-02 | 1.00e+00 | 2.139 | 2 | 23 | 341 |
GO:0042826 | histone deacetylase binding | 7.46e-02 | 1.00e+00 | 3.695 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 5 | 61 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 8.20e-02 | 1.00e+00 | 3.553 | 1 | 3 | 64 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 8.57e-02 | 1.00e+00 | 3.487 | 1 | 5 | 67 |
GO:0016568 | chromatin modification | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 3 | 68 |
GO:0030308 | negative regulation of cell growth | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 3 | 70 |
GO:0005789 | endoplasmic reticulum membrane | 9.16e-02 | 1.00e+00 | 1.957 | 2 | 7 | 387 |
GO:0030496 | midbody | 9.30e-02 | 1.00e+00 | 3.363 | 1 | 6 | 73 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 2 | 76 |
GO:0005938 | cell cortex | 9.79e-02 | 1.00e+00 | 3.286 | 1 | 6 | 77 |
GO:0030529 | ribonucleoprotein complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 5 | 82 |
GO:0005215 | transporter activity | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.05e-01 | 1.00e+00 | 3.178 | 1 | 2 | 83 |
GO:0030027 | lamellipodium | 1.11e-01 | 1.00e+00 | 3.094 | 1 | 3 | 88 |
GO:0020037 | heme binding | 1.11e-01 | 1.00e+00 | 3.094 | 1 | 3 | 88 |
GO:0006886 | intracellular protein transport | 1.12e-01 | 1.00e+00 | 3.077 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 1.13e-01 | 1.00e+00 | 3.061 | 1 | 4 | 90 |
GO:0003677 | DNA binding | 1.25e-01 | 1.00e+00 | 1.251 | 3 | 52 | 947 |
GO:0005515 | protein binding | 1.30e-01 | 1.00e+00 | 0.543 | 8 | 198 | 4124 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.34e-01 | 1.00e+00 | 2.811 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.35e-01 | 1.00e+00 | 2.798 | 1 | 2 | 108 |
GO:0042981 | regulation of apoptotic process | 1.39e-01 | 1.00e+00 | 2.746 | 1 | 4 | 112 |
GO:0003924 | GTPase activity | 1.47e-01 | 1.00e+00 | 2.658 | 1 | 7 | 119 |
GO:0006184 | GTP catabolic process | 1.60e-01 | 1.00e+00 | 2.531 | 1 | 7 | 130 |
GO:0030168 | platelet activation | 1.72e-01 | 1.00e+00 | 2.413 | 1 | 5 | 141 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.73e-01 | 1.00e+00 | 2.403 | 1 | 5 | 142 |
GO:0044212 | transcription regulatory region DNA binding | 1.75e-01 | 1.00e+00 | 2.393 | 1 | 13 | 143 |
GO:0005829 | cytosol | 2.02e-01 | 1.00e+00 | 0.750 | 4 | 88 | 1787 |
GO:0007264 | small GTPase mediated signal transduction | 2.09e-01 | 1.00e+00 | 2.110 | 1 | 8 | 174 |
GO:0004842 | ubiquitin-protein transferase activity | 2.14e-01 | 1.00e+00 | 2.069 | 1 | 17 | 179 |
GO:0005730 | nucleolus | 2.15e-01 | 1.00e+00 | 0.889 | 3 | 74 | 1217 |
GO:0005739 | mitochondrion | 2.17e-01 | 1.00e+00 | 1.189 | 2 | 32 | 659 |
GO:0003713 | transcription coactivator activity | 2.19e-01 | 1.00e+00 | 2.029 | 1 | 21 | 184 |
GO:0005975 | carbohydrate metabolic process | 2.21e-01 | 1.00e+00 | 2.014 | 1 | 10 | 186 |
GO:0016567 | protein ubiquitination | 2.23e-01 | 1.00e+00 | 1.998 | 1 | 14 | 188 |
GO:0005856 | cytoskeleton | 2.26e-01 | 1.00e+00 | 1.983 | 1 | 8 | 190 |
GO:0005743 | mitochondrial inner membrane | 2.33e-01 | 1.00e+00 | 1.931 | 1 | 9 | 197 |
GO:0005525 | GTP binding | 2.33e-01 | 1.00e+00 | 1.931 | 1 | 12 | 197 |
GO:0005634 | nucleus | 2.39e-01 | 1.00e+00 | 0.473 | 6 | 158 | 3246 |
GO:0006281 | DNA repair | 2.39e-01 | 1.00e+00 | 1.888 | 1 | 24 | 203 |
GO:0008134 | transcription factor binding | 2.45e-01 | 1.00e+00 | 1.846 | 1 | 10 | 209 |
GO:0006355 | regulation of transcription, DNA-templated | 2.46e-01 | 1.00e+00 | 1.071 | 2 | 31 | 715 |
GO:0019899 | enzyme binding | 2.46e-01 | 1.00e+00 | 1.839 | 1 | 7 | 210 |
GO:0007268 | synaptic transmission | 2.50e-01 | 1.00e+00 | 1.811 | 1 | 7 | 214 |
GO:0003723 | RNA binding | 2.83e-01 | 1.00e+00 | 1.605 | 1 | 22 | 247 |
GO:0006508 | proteolysis | 3.00e-01 | 1.00e+00 | 1.509 | 1 | 11 | 264 |
GO:0008285 | negative regulation of cell proliferation | 3.12e-01 | 1.00e+00 | 1.439 | 1 | 11 | 277 |
GO:0005925 | focal adhesion | 3.17e-01 | 1.00e+00 | 1.413 | 1 | 14 | 282 |
GO:0009986 | cell surface | 3.25e-01 | 1.00e+00 | 1.368 | 1 | 5 | 291 |
GO:0005524 | ATP binding | 3.36e-01 | 1.00e+00 | 0.752 | 2 | 37 | 892 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.49e-01 | 1.00e+00 | 1.245 | 1 | 17 | 317 |
GO:0055085 | transmembrane transport | 3.60e-01 | 1.00e+00 | 1.191 | 1 | 13 | 329 |
GO:0070062 | extracellular vesicular exosome | 3.77e-01 | 1.00e+00 | 0.458 | 3 | 51 | 1641 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.01e-01 | 1.00e+00 | 0.995 | 1 | 21 | 377 |
GO:0005783 | endoplasmic reticulum | 4.04e-01 | 1.00e+00 | 0.979 | 1 | 12 | 381 |
GO:0042803 | protein homodimerization activity | 4.42e-01 | 1.00e+00 | 0.811 | 1 | 13 | 428 |
GO:0045087 | innate immune response | 4.60e-01 | 1.00e+00 | 0.733 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.63e-01 | 1.00e+00 | 0.720 | 1 | 29 | 456 |
GO:0005887 | integral component of plasma membrane | 5.46e-01 | 1.00e+00 | 0.386 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 5.73e-01 | 1.00e+00 | 0.282 | 1 | 24 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.88e-01 | 1.00e+00 | 0.222 | 1 | 29 | 644 |
GO:0016021 | integral component of membrane | 6.26e-01 | 1.00e+00 | -0.023 | 2 | 19 | 1526 |
GO:0044822 | poly(A) RNA binding | 6.71e-01 | 1.00e+00 | -0.089 | 1 | 45 | 799 |
GO:0044281 | small molecule metabolic process | 6.91e-01 | 1.00e+00 | -0.168 | 1 | 35 | 844 |
GO:0005886 | plasma membrane | 7.17e-01 | 1.00e+00 | -0.248 | 2 | 46 | 1784 |
GO:0005737 | cytoplasm | 7.24e-01 | 1.00e+00 | -0.225 | 3 | 127 | 2633 |
GO:0006351 | transcription, DNA-templated | 7.81e-01 | 1.00e+00 | -0.518 | 1 | 47 | 1076 |